tiprankstipranks
Morning Movers: UnitedHealth sinks following CEO exit and outlook suspension
PremiumThe FlyMorning Movers: UnitedHealth sinks following CEO exit and outlook suspension
16d ago
Altimmune secures up to $100M in credit facility
Premium
The Fly
Altimmune secures up to $100M in credit facility
16d ago
Altimmune Secures $100 Million Credit Facility
Premium
Company Announcements
Altimmune Secures $100 Million Credit Facility
16d ago
Altimmune’s Pemvidutide: A Promising Catalyst with Blockbuster Potential and Strong Financial Backing
PremiumRatingsAltimmune’s Pemvidutide: A Promising Catalyst with Blockbuster Potential and Strong Financial Backing
2M ago
Altimmune’s Strategic Positioning and Promising Future in Obesity and MASH Treatment Markets
Premium
Ratings
Altimmune’s Strategic Positioning and Promising Future in Obesity and MASH Treatment Markets
2M ago
Altimmune’s Pemvidutide: A Promising Best-in-Class Therapy with Broad Potential and Strong Buy Rating
Premium
Ratings
Altimmune’s Pemvidutide: A Promising Best-in-Class Therapy with Broad Potential and Strong Buy Rating
2M ago
Evercore bullish on Altimmune, likes drug move into alcohol related disease
PremiumThe FlyEvercore bullish on Altimmune, likes drug move into alcohol related disease
3M ago
Promising Potential of Altimmune’s Pemvidutide Drives Buy Rating Amid Expanding Indications and Strong Market Outlook
Premium
Ratings
Promising Potential of Altimmune’s Pemvidutide Drives Buy Rating Amid Expanding Indications and Strong Market Outlook
3M ago
Altimmune’s Pemvidutide: Promising Future with IMPACT Trial and Market Expansion
Premium
Ratings
Altimmune’s Pemvidutide: Promising Future with IMPACT Trial and Market Expansion
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100